<![CDATA[DNA/RNA-Based NGS Test Improves Diagnostic Accuracy in Bile Duct Strictures]]>

Summary: For years, doctors struggled to tell if a narrow bile duct was cancer or just harmless swelling. Traditional tests missed the mark, catching cancer only 44% of the time. This led to a lot of health anxiety, repeat tests, and unnecessary surgeries for patients.

Now, a new DNA and RNA test called BiliSeq is changing the game. In a large study, BiliSeq caught 82% of cancers. Even better, it found specific gene mutations in nearly a quarter of the cases. This helps doctors choose the exact right targeted medicine for each patient, taking the guesswork out of bile duct cancer diagnosis and getting patients back to their normal lives faster!

Source: cancernetwork URL: cancernetwork.com/view/dna-rna-based-ngs-test-improves-diagnostic-accuracy-in-bile-duct-strictures (opens in new tab)